Efficacy News and Research

RSS
Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

The benefits of using fractional doses of COVID-19 vaccines

The benefits of using fractional doses of COVID-19 vaccines

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

How effective is mRNA vaccination in multiple myeloma patients?

How effective is mRNA vaccination in multiple myeloma patients?

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Triple drug regimen proven effective against non-structural protein-1 of SARS-CoV-2

Dual therapeutic potential of zapnometinib against COVID-19

Dual therapeutic potential of zapnometinib against COVID-19

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Adenosine receptor agonists provide therapeutic target in mouse SARS-CoV-2 infection

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

Targeting necroptosis using a necroptosis inhibitor lessens myositis-induced muscle weakness

Targeting necroptosis using a necroptosis inhibitor lessens myositis-induced muscle weakness

Masks made of woven fabrics are lousy air filters

Masks made of woven fabrics are lousy air filters

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Phase 2/3 study of oral RHB-107 in non-hospitalized COVID-19 patients shows promising results

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Researchers launch a multi-center trial to investigate new treatment for pediatric type 1 diabetes

Intensive treatment for patients with Crohn's disease found to be safe

Intensive treatment for patients with Crohn's disease found to be safe

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.